SCHEMBL7923052

SCHEMBL7923052

Cc1ccc(Oc2ccc(S(=O)(=O)N3CCCCC[C@@H]3C(=O)NO)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 13/20 0.77
MMP3 P08254 9/20 0.77
MMP7 P09237 8/20 0.77
MMP13 P45452 7/20 0.77
MMP9 P14780 5/20 0.58
MMP2 P08253 2/20 0.58
MMP8 P22894 1/20 0.58
GAA P10253 2/20 0.57
ADAM17 P78536 2/20 0.57
HPGD P15428 1/20 0.57
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57
MAPT P10636 1/20 0.57
KCNQ1 P51787 2/20 0.55
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
HCRTR1 O43613 1/20 0.55
HCRTR2 O43614 1/20 0.55
CYP3A4 P08684 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7923056 1.00 MMP1 (0.77) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7535524 0.99 MMP1 (0.75) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7535528 0.99 MMP1 (0.75) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7923785 0.91 MMP1 (0.93) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7923788 0.91 MMP1 (0.93) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7533059 0.90 MMP1 (0.91) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7568599 0.90 MMP1 (0.75) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7533064 0.90 MMP1 (0.91) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7923015 0.90 MMP1 (0.75) MMP1MMP3MMP7MMP13MMP9
SCHEMBL7923021 0.90 MMP1 (0.75) MMP1MMP3MMP7MMP13MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US claimed
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US disclosed